BIB - ProShares Ultra Nasdaq Biotechnology
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
47.69
+0.13 (+0.27%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
| Previous Close | 47.56 |
| Open | 47.23 |
| Bid | 46.90 x 800 |
| Ask | 48.00 x 800 |
| Day's Range | 46.88 - 47.81 |
| 52 Week Range | 36.05 - 70.82 |
| Volume | 58,306 |
| Avg. Volume | 116,695 |
| Net Assets | 189.65M |
| NAV | 47.57 |
| PE Ratio (TTM) | N/A |
| Yield | 0.00% |
| YTD Return | 10.40% |
| Beta (3Y Monthly) | 2.65 |
| Expense Ratio (net) | 0.95% |
| Inception Date | 2010-04-06 |
Trade prices are not sourced from all markets
- Investopedia
BIB Versus LABU: Comparing Leveraged Biotech ETFs
Read a comparison of BIB and LABU and a description of the characteristics and historical performance of these leveraged biotech ETFs.
- Zacks
Biotech ETFs in Focus on String of Q1 Earnings Beats
Let's take a sneak peek at some ETFs having high exposure to some impactful biotechnological companies on the release of Q1 earnings results.
- Zacks
Will Biotech ETFs Continue to Rally in Q1 Earnings?
Here we study the possible impact of some major Q1 earnings releases on certain biotech ETFs .
- Investor's Business Daily
Swing Trade In Biotech Sector Gave The Best Of Both Worlds
Stocks in the biotech sector pose a problem for a swing trade. We take profits quicker, so we need to avoid big losses. Biotech stocks make that difficult.
